{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:23:28Z","timestamp":1791051808766,"version":"4.1.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.neurobiolaging.2005.09.020","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T07:22:43Z","timestamp":1130484163000},"page":"1537-1553","source":"Crossref","is-referenced-by-count":18,"title":["Current knowledge of chromosome 12 susceptibility genes for late-onset Alzheimer's disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Alessia","family":"D\u2019Introno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Solfrizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Colacicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Capurso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Todarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capurso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick G.","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/bbrc.1999.1295","article-title":"Association between an alpha[2] macroglobulin DNA polymorphism and late-onset Alzheimer's disease","volume":"264","author":"Alvarez","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0169-328X(02)00203-6","article-title":"LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes","volume":"104","author":"Arelin","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/1096-8628(20001204)96:6<775::AID-AJMG15>3.0.CO;2-E","article-title":"Identical distribution of the alpha 2-macroglobulin pentanucleotide deletion in subjects with Alzheimer disease and controls in a German population","volume":"96","author":"Bagli","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(98)00294-8","article-title":"Low density lipoprotein receptor related protein gene exon 3 polymorphism association with Alzheimer's disease in Chinese","volume":"247","author":"Baum","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(98)00888-X","article-title":"The polymorphism in exon 3 of the low density lipoprotein receptor-related protein gene is weakly associated with Alzheimer's disease","volume":"259","author":"Beffert","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib6","unstructured":"Bertram L, McQueen M, Mullin K, Blacker D, Tanzi R. The AlzGene Database. Alzheimer Research Forum. Available at: http:\/\/www.alzgene.org."},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0531-5565(00)00193-5","article-title":"Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family based methodologies","volume":"35","author":"Bertram","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib8","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/jmg.2003.016980","article-title":"No association between a previously reported OLR1 3\u2032-UTR polymorphism and Alzheimer's disease in a large family sample","volume":"41","author":"Bertram","year":"2004","journal-title":"J Med Gen"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib9","first-page":"71","article-title":"Association between low-density lipoprotein receptor-related protein gene, butyrylcholinesterase gene and Alzheimer\u2019 s disease in Chinese","volume":"16","author":"Bi","year":"2001","journal-title":"Chin Med Sci J"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib10","doi-asserted-by":"crossref","first-page":"24649","DOI":"10.1074\/jbc.274.35.24649","article-title":"Purification and characterization of the serum amyloid A3 enhancer factor","volume":"274","author":"Bing","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/1243","article-title":"Alpha-2 macroglobulin is genetically associated with Alzheimer disease","volume":"19","author":"Blacker","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/8732","article-title":"In reply","volume":"22","author":"Blacker","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/hmg\/ddg007","article-title":"Results of a high-resolution genome screen of 437 Alzheimer's disease families","volume":"12","author":"Blacker","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s007020070052","article-title":"No association between the alpha2-macroglobulin [A2M] deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression","volume":"107","author":"Blennow","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib15","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1096\/fasebj.6.15.1281457","article-title":"Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics","volume":"6","author":"Borth","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0304-3940(00)01304-5","article-title":"Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender","volume":"289","author":"Bullido","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib17","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neurobiolaging.2003.10.006","article-title":"Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's","volume":"25","author":"Bullido","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00001756-200506210-00028","article-title":"Genetic studies of A2M and BACE1 genes in Chinese Han Alzheimer's disease patients","volume":"16","author":"Cai","year":"2005","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2003.10.008","article-title":"Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients","volume":"218","author":"Camelo","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib20","doi-asserted-by":"crossref","first-page":"6142","DOI":"10.1523\/JNEUROSCI.17-16-06142.1997","article-title":"Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased \u03b2-Amyloidogenesis","volume":"17","author":"Cataldo","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jnen\/62.10.999","article-title":"Lack of association between the levels of the low-density lipoprotein receptor-related protein [LRP] and either Alzheimer dementia or LRP exon 3 genotype","volume":"62","author":"Causevic","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(99)00421-8","article-title":"Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease","volume":"269","author":"Chen","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2003.08.002","article-title":"Association of alpha 2-macroglobulin polymorphisms and Alzheimer disease in Mainland Han Chinese","volume":"217","author":"Chen","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.ypg.0000056174.32550.7e","article-title":"Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population","volume":"13","author":"Clarimon","year":"2003","journal-title":"Psychiatric Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib25","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/archneur.1997.00550220087019","article-title":"Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease","volume":"54","author":"Clatworthy","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00415-005-0658-6","article-title":"Interaction between interleukin-6 and intercellular adhesion molecule-1 genes and Alzheimer's disease risk","volume":"252","author":"Combarros","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib27","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1074\/jbc.M010612200","article-title":"The binding of oxidized low density lipoprotein [ox-LDL] to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide","volume":"276","author":"Cominacini","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/2677","article-title":"HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy","volume":"4","author":"Corder","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(99)00470-X","article-title":"The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case\u2013control sample","volume":"270","author":"Crawford","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.24.2.865-874.2004","article-title":"Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1","volume":"24","author":"Christensen","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib31","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1074\/jbc.M205455200","article-title":"Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid","volume":"278","author":"Curtain","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib32","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1128\/MCB.14.4.2545","article-title":"Cellular protein interactions with herpes simplex virus type 1 oriS","volume":"14","author":"Dabrowski","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1212\/WNL.54.2.438","article-title":"Alpha2 macroglobulin and the risk of Alzheimer's disease","volume":"54","author":"Dodel","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/8724","article-title":"Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK","volume":"22","author":"Dow","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib35","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1046\/j.1471-4159.1998.70031182.x","article-title":"Alpha2-macroglobulin attenuates beta-amyloid peptide 1\u201340 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons","volume":"70","author":"Du","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib36","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/gerona\/60.3.280","article-title":"Polymorphisms in oxidised low-density lipoprotein receptor-1 [OLR1] gene and risk of Alzheimer's disease","volume":"60","author":"D\u2019Introno","year":"2005","journal-title":"J Gerontol A: Med Sci Biol Sci"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00702-003-0055-1","article-title":"Neuroinflammatory perspectives on the two faces of Alzheimer's disease","volume":"111","author":"Eikelenboom","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib38","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0168-9525(01)02342-3","article-title":"SNP association studies in Alzheimer's disease highlight problems for complex disease analysis","volume":"17","author":"Emahazion","year":"2001","journal-title":"Trends Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(97)00634-4","article-title":"No association between the low density lipoprotein receptor-related protein [LRP] gene and late-onset Alzheimer's disease in a community-based sample","volume":"233","author":"Fallin","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/hmg\/ddg037","article-title":"Identification of multiple loci for Alzheimer disease in a consanguineous Israeli-Arab community","volume":"12","author":"Farrer","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib41","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000133578","article-title":"Localization of the transcription factor SP1 gene to human chromosome 12q12\u2013q13.2","volume":"64","author":"Gaynor","year":"1993","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1212\/WNL.54.2.433","article-title":"Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD","volume":"54","author":"Gibson","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib43","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/349704a0","article-title":"Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease","volume":"349","author":"Goate","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib44","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneumeth.2003.09.005","article-title":"The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains","volume":"132","author":"Gutala","year":"2004","journal-title":"J Neurosci Meth"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib45","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1097\/00001756-200011090-00039","article-title":"Association of APOE promoter but not A2M polymorphisms with risk of developing Alzheimer's disease","volume":"11","author":"Halimi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ajmg.10294","article-title":"The real problem in association studies","volume":"114","author":"Hardy","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-0004.1996.tb02347.x","article-title":"Short report on DNA marker at candidate locus. Two new alleles in the tetranucleotide repeat polymorphism in the LDL-receptor-related protein (LRP) gene","volume":"50","author":"Harris","year":"1996","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1034\/j.1399-0004.2000.580410.x","article-title":"Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population","volume":"58","author":"Hatanaka","year":"2000","journal-title":"Clin Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib49","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00001756-200004270-00005","article-title":"Alpha2-macroglobulin gene polymorphisms show racial diversity and are not associated with Alzheimer's disease","volume":"11","author":"Higuchi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib51","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1212\/WNL.50.6.1905","article-title":"Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease","volume":"50","author":"Hollenbach","year":"1998","journal-title":"Neurology"},{"issue":"Suppl","key":"10.1016\/j.neurobiolaging.2005.09.020_bib52","first-page":"471","article-title":"Evidence of interaction between susceptibility loci on chromosomes 1, 10 and 12 in late-onset Alzheimer's disease [LOAD]","volume":"73","author":"Holmans","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib53","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.53.3.642","article-title":"No association of alpha-2 macroglobulin gene five-nucleotide deletion with AD in Taiwan Chinese","volume":"53","author":"Hu","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(00)00443-3","article-title":"Genetic risk factors of sporadic Alzheimer's disease among Chinese in Taiwan","volume":"181","author":"Hu","year":"2000","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib55","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1073\/pnas.95.6.3275","article-title":"Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation","volume":"95","author":"Hughes","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib56","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1253\/circj.66.1060","article-title":"Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells","volume":"66","author":"Imanishi","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/ng749","article-title":"Replication validity of genetic association studies","volume":"29","author":"Ioannidis","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(05)77844-2","article-title":"HSV-1 and risk of Alzheimer's disease","volume":"352","author":"Itzhaki","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neulet.2004.10.038","article-title":"Candidate gene association study of solute carrier family 11a members 1 [SLC11A1] and 2 (SLC11A2) genes in Alzheimer's disease","volume":"374","author":"Jamieson","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib60","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00041444-200203000-00007","article-title":"Alpha2-macroglobulin exon 24 [Val-1000-Ile] polymorphism is not associated with late-onset sporadic Alzheimer's dementia in the Hungarian population","volume":"12","author":"Janka","year":"2002","journal-title":"Psychiatric Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0022-510X(00)00494-9","article-title":"Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans","volume":"184","author":"Jhoo","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2004.03.066","article-title":"Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population","volume":"363","author":"Kabbara","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(98)00141-4","article-title":"Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene","volume":"244","author":"Kamboh","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib64","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer's disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/WNL.49.1.56","article-title":"Genetic association of the low density lipoprotein receptor-related protein gene [LRP], an apolipoprotein E receptor, with late-onset Alzheimer's disease","volume":"49","author":"Kang","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib66","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/8.2.237","article-title":"A full genome scan for late onset Alzheimer's disease","volume":"8","author":"Kehoe","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)01660-3","article-title":"Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease","volume":"302","author":"Ki","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.ypg.0000129204.58574.c2","article-title":"Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease","volume":"14","author":"K\u00f6lsch","year":"2004","journal-title":"Psychiatric Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ajmg.b.20043","article-title":"Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease","volume":"121","author":"Kolsch","year":"2003","journal-title":"Am J Med Genet B: Neuropsychiatric Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00537-6","article-title":"Alpha-2 macroglobulin gene in early and late-onset Alzheimer disease","volume":"271","author":"Korovaitseva","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib71","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/WNL.55.5.678","article-title":"The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis","volume":"55","author":"Koster","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib72","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0531-5565(00)00113-3","article-title":"Alpha2-macroglobulin in late-onset Alzheimer's disease","volume":"35","author":"Kovacs","year":"2000","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(99)00604-7","article-title":"Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease","volume":"273","author":"Kovacs","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jnr.20112","article-title":"Computer-identified nuclear localization signal in exon 1A of the transporter DMT1 is essentially ineffective in nuclear targeting","volume":"76","author":"Kuo","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib75","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/S0140-6736(05)78749-3","article-title":"Association at LRP gene locus with sporadic late-onset Alzheimer's disease","volume":"351","author":"Lambert","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib76","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s100480050061","article-title":"Is the LDL receptor-related protein involved in Alzheimer's disease?","volume":"2","author":"Lambert","year":"1999","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib77","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/oxfordjournals.hmg.a018918","article-title":"The transcriptional factor LBP-1c\/CP2\/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease","volume":"9","author":"Lambert","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib78","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jmg.40.6.424","article-title":"Association of 3\u2032-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease","volume":"40","author":"Lambert","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/geno.1999.5875","article-title":"Molecular cloning and characterization of the human glycogen synthase kinase-3beta promoter","volume":"60","author":"Lau","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib80","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(97)13381-X","article-title":"Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population","volume":"222","author":"Lendon","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib81","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.20.4.1116","article-title":"Upregulation of endothelial receptor for oxidized LDL [LOX-1] by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors","volume":"20","author":"Li","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib82","doi-asserted-by":"crossref","first-page":"15688","DOI":"10.1073\/pnas.0403535101","article-title":"Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family","volume":"101","author":"Li","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib83","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/7.12.1953","article-title":"Genetic association of an alpha2-macroglobulin [Val1000lle] polymorphism and Alzheimer's disease","volume":"7","author":"Liao","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib84","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1021\/bi990205o","article-title":"Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease","volume":"38","author":"Liu","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jech.2003.016451","article-title":"Consistency in gene-Alzheimer's disease association studies","volume":"59","author":"Llorca","year":"2005","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib86","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00439-002-0802-7","article-title":"Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12","volume":"111","author":"Luedecking-Zimmer","year":"2002","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib87","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajmg.b.10026","article-title":"Association of the 3\u2032-UTR transcription factor LBP-1c\/CP2\/LSF polymorphism with late-onset Alzheimer's disease","volume":"117","author":"Luedecking-Zimmer","year":"2003","journal-title":"Am J Med Genet :B Neuropsychiatric Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib88","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1086\/324773","article-title":"Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics","volume":"70","author":"Mayeux","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib89","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajmg.1474","article-title":"Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in northern Ireland","volume":"105","author":"McIlroy","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib90","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0735-1097(02)01803-X","article-title":"Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor","volume":"39","author":"Mehta","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib91","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ajmg.10183","article-title":"Full genome screen for Alzheimer disease: stage II analysis","volume":"114","author":"Myers","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib92","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/1531-8249(199909)46:3<382::AID-ANA14>3.0.CO;2-5","article-title":"Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population","volume":"46","author":"Myllykangas","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0304-3940(00)01758-4","article-title":"Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease","volume":"299","author":"Nacmias","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib94","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1046\/j.1471-4159.1997.69051904.x","article-title":"Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein","volume":"69","author":"Narita","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib95","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(96)90284-6","article-title":"Apolipoprotein E genotyping in Alzheimer's disease","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000051274","article-title":"Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer's disease","volume":"12","author":"Nicosia","year":"2001","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib97","series-title":"Proceedings of the 53rd Annual Meeting of The American Society of Human Genetics","article-title":"Strong pattern of association with AD in a 210kb region on chromosome 12","author":"Nowotny","year":"2003"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.b.20146","article-title":"Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 polymorphism in Alzheimer's disease","volume":"126","author":"Panza","year":"2004","journal-title":"Am J Med Genet B: Neuropsychiatric Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib99","first-page":"166","article-title":"LBP-1c\/CP2\/LSF gene polymorphism and risk of sporadic Alzheimer's disease","volume":"75","author":"Panza","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib100","doi-asserted-by":"crossref","first-page":"40859","DOI":"10.1074\/jbc.M306580200","article-title":"Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP)","volume":"278","author":"Paromov","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib101","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/jama.278.15.1237","article-title":"Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12","volume":"278","author":"Pericak-Vance","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib102","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ajmg.1371","article-title":"Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls","volume":"105","author":"Perry","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s100480100110","article-title":"An association between a subset of Finnish late-onset Alzheimer's disease and alpha2-macroglobulin","volume":"3","author":"Pirskanen","year":"2001","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0304-3940(01)02130-9","article-title":"Chromosome 12 and late-onset Alzheimer's disease","volume":"310","author":"Poduslo","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/ajmg.10395","article-title":"Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease","volume":"110","author":"Poduslo","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib106","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.ejhg.5200651","article-title":"Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease","volume":"9","author":"Prince","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib107","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neulet.2004.05.023","article-title":"No association between polymorphisms in the lectin-like oxidised low density lipoprotein receptor (ORL1) gene on chromosome 12 and Alzheimer's disease in a UK cohort","volume":"366","author":"Pritchard","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib108","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neulet.2005.03.016","article-title":"Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease","volume":"382","author":"Pritchard","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib109","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/376775a0","article-title":"Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene","volume":"376","author":"Rogaev","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib110","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jama.280.7.614","article-title":"Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity","volume":"280","author":"Rogaeva","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/8729","article-title":"An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease","volume":"22","author":"Rogaeva","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib112","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(99)00972-6","article-title":"The deletion polymorphism and Val1000Ile in alpha-2-macroglobulin and Alzheimer disease in Caribbean Hispanics","volume":"279","author":"Romas","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib113","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3940(02)01218-1","article-title":"A polymorphism in the complement component C1r is not associated with sporadic Alzheimer's disease","volume":"336","author":"Rosenmann","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib114","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/8726","article-title":"Alpha-2 macroglobulin gene and Alzheimer disease","volume":"22","author":"Rudrasingham","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0304-3940(01)02342-4","article-title":"Case\u2013control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease","volume":"316","author":"Sanchez-Guerra","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib116","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib117","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/hmg\/ddg310","article-title":"Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin","volume":"12","author":"Saunders","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib118","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.1073\/pnas.94.21.11669","article-title":"Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death","volume":"94","author":"Sawa","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib119","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/CCLM.2002.052","article-title":"Alpha2-macroglobulin deletion polymorphism and plasma levels in late onset Alzheimer's disease","volume":"40","author":"Scacchi","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib120","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1471-4159.1993.tb13420.x","article-title":"Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein","volume":"60","author":"Schulze","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s100480050026","article-title":"No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease","volume":"1","author":"Scott","year":"1998","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib122","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.281.6.513","article-title":"Further evidence linking late-onset Alzheimer disease with chromosome 12","volume":"281","author":"Scott","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib123","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1086\/302828","article-title":"Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity","volume":"66","author":"Scott","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib124","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a novel gene bearing missense mutations in early onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0304-3940(99)00541-8","article-title":"Genetic association between alpha-2 macroglobulin and Japanese sporadic Alzheimer's disease","volume":"271","author":"Shibata","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib126","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0304-3940(00)01330-6","article-title":"No genetic association between alpha-2 macroglobulin I1000V polymorphism and Japanese sporadic Alzheimer's disease","volume":"290","author":"Shibata","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib127","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0198-45","article-title":"Association of a human G-protein beta3 subunit variant with hypertension","volume":"18","author":"Siffert","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib128","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/00001756-199905140-00021","article-title":"Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies","volume":"10","author":"Singleton","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib129","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/brain\/awh179","article-title":"Familial clustering and genetic risk for dementia in a genetically isolated Dutch population","volume":"127","author":"Sleegers","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/WNL.54.2.443","article-title":"Alpha2-macroglobulin polymorphism is not associated with AD or AD-type neuropathology in the Japanese","volume":"54","author":"Sodeyama","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib131","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0896-6273(03)00367-2","article-title":"The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide","volume":"39","author":"Soucek","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib132","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2008-1040852","article-title":"Molecular genetics of Alzheimer disease","volume":"19","author":"St. George-Hyslop","year":"1999","journal-title":"Semin Neurol"},{"issue":"Suppl","key":"10.1016\/j.neurobiolaging.2005.09.020_bib133","first-page":"471","article-title":"Further evidence of linkage of Alzheimer's disease on chromosome 12","volume":"73","author":"Stanton","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib134","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0304-3940(03)00438-5","article-title":"Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease","volume":"344","author":"Styczynska","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0304-3940(02)00430-5","article-title":"Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease","volume":"328","author":"Tang","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib136","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/jmg.38.4.232","article-title":"Genetic association of an LBP-1c\/CP2\/LSF gene polymorphism with late onset Alzheimer's disease","volume":"38","author":"Taylor","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib137","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","article-title":"The role of inflammation in Alzheimer's disease","volume":"37","author":"Tuppo","year":"2005","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib138","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0021-9150(00)00657-2","article-title":"Sequencing of the coding exons of the LRP1 and LDLR genes on individual DNA samples reveals novel mutations in both genes","volume":"154","author":"Van Leuven","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib139","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/1531-8249(200009)48:3<400::AID-ANA22>3.0.CO;2-L","article-title":"Alpa2-macroglobulin gene and Alzheimer's disease: confirmation of association by haplotypes analyses","volume":"48","author":"Verpillat","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.ejhg.5200644","article-title":"Use of haplotype information to test involvement of the LRP gene in Alzheimer's disease in the French population","volume":"9","author":"Verpillat","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s004390000445","article-title":"Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease","volume":"108","author":"Wang","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib142","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0304-3940(97)00304-2","article-title":"Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease","volume":"227","author":"Wavrant-DeVrieze","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib143","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s004390050980","article-title":"Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease","volume":"104","author":"Wavrant-DeVrieze","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib144","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(99)00035-X","article-title":"No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease","volume":"262","author":"Wavrant-DeVrieze","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(05)77848-X","article-title":"LRP gene and late-onset Alzheimer's disease","volume":"352","author":"Woodward","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib146","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1001\/jama.280.7.619","article-title":"Genetic studies on chromosome 12 in late-onset Alzheimer disease","volume":"280","author":"Wu","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib147","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0002-9440(10)65340-0","article-title":"Up-regulated production and activation of the complement system in Alzheimer's disease brain","volume":"154","author":"Yasojima","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib148","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/MCB.14.3.1776","article-title":"Characterization of a family of related cellular transcription factors which can modulate human immunodeficiency virus type 1 transcription in vitro","volume":"14","author":"Yoon","year":"1994","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib149","doi-asserted-by":"crossref","first-page":"20128","DOI":"10.1074\/jbc.273.32.20128","article-title":"The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2\/LSF\/LBP1","volume":"273","author":"Zambrano","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib150","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1212\/WNL.59.5.756","article-title":"Genetic association of alpha2-macroglobulin polymorphisms with AD in southern Italy","volume":"59","author":"Zappia","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib151","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archneur.61.3.341","article-title":"Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms","volume":"6","author":"Zappia","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib152","first-page":"1","article-title":"Neither the tumor necrosis factor alpha-308 A\/G polymorphism nor the alpha2-macroglobulin polymorphism was associated with late-onset Alzheimer's disease in the Chinese population","volume":"31","author":"Zhang","year":"2004","journal-title":"Yi Chuan Xue Bao"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib153","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(00)01518-4","article-title":"Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients","volume":"294","author":"Zill","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib154","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/geno.1998.5306","article-title":"A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution","volume":"50","author":"Zubenko","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/hmg\/3.1.215-a","article-title":"Tetranucleotide length polymorphism 5\u2032 of the alpha 2-macroglobulin receptor [A2MR]\/LDL receptor-related protein [LRP] gene","volume":"3","author":"Zuliani","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2005.09.020_bib156","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00439-002-0819-y","article-title":"Positive results in association studies are associated with departure from Hardy\u2013Weinberg equilibrium: hint for genotyping error?","volume":"111","author":"Xu","year":"2002","journal-title":"Hum Genet"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005002940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458005002940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T11:46:09Z","timestamp":1554291969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458005002940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":156,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0197458005002940"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.09.020","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}